HomeSVNS • LON
add
Solvonis Therapeutics PLC
Previous close
GBX 0.13
Day range
GBX 0.12 - GBX 0.15
Year range
GBX 0.11 - GBX 0.21
Market cap
3.29M GBP
Avg Volume
9.60M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
In the news
Financials
Income Statement
Revenue
Net income
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 335.00K | -67.35% |
Net income | -335.00K | 80.20% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -293.75K | 68.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 757.00K | 388.39% |
Total assets | 3.20M | 31.59% |
Total liabilities | 119.00K | -70.83% |
Total equity | 3.08M | — |
Shares outstanding | 2.30B | — |
Price to book | ∞ | — |
Return on assets | -25.33% | — |
Return on capital | -26.35% | — |
Cash Flow
Net change in cash
| (GBP) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -335.00K | 80.20% |
Cash from operations | -149.00K | -454.76% |
Cash from investing | -20.00K | 13.04% |
Cash from financing | 0.00 | — |
Net change in cash | -183.00K | — |
Free cash flow | 261.62K | — |
About
Founded
2017
Website
Employees
3
